The protein C anticoagulant pathway.
1992; Volume: 12; Issue: 2 Linguagem: Inglês
10.1161/01.atv.12.2.135
ISSN2330-9199
Autores Tópico(s)Venous Thromboembolism Diagnosis and Management
ResumoHomeArteriosclerosis and Thrombosis: A Journal of Vascular BiologyVol. 12, No. 2The protein C anticoagulant pathway. Free AccessAbstractPDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessAbstractPDF/EPUBThe protein C anticoagulant pathway. C T Esmon C T EsmonC T Esmon Oklahoma Medical Research Foundation, Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City 73104. Originally published1 Feb 1992https://doi.org/10.1161/01.ATV.12.2.135Arteriosclerosis and Thrombosis: A Journal of Vascular Biology. 1992;12:135–145 Previous Back to top Next FiguresReferencesRelatedDetailsCited By He S, Cao H, Thålin C, Svensson J, Blombäck M and Wallén H (2020) The Clotting Trigger Is an Important Determinant for the Coagulation Pathway In Vivo or In Vitro—Inference from Data Review, Seminars in Thrombosis and Hemostasis, 10.1055/s-0040-1718888, 47:01, (063-073), Online publication date: 1-Feb-2021. Sanrattana W, Sefiane T, Smits S, van Kleef N, Fens M, Lenting P, Maas C and de Maat S (2021) A reactive center loop–based prediction platform to enhance the design of therapeutic SERPINs, Proceedings of the National Academy of Sciences, 10.1073/pnas.2108458118, 118:45, Online publication date: 9-Nov-2021. Castiglione M, Jiang Y, Mazzeo C, Lee S, Chen J, Kaushansky K, Yin W, Lin R, Zheng H and Zhan H (2020) Endothelial JAK2V617F mutation leads to thrombosis, vasculopathy, and cardiomyopathy in a murine model of myeloproliferative neoplasm, Journal of Thrombosis and Haemostasis, 10.1111/jth.15095, 18:12, (3359-3370), Online publication date: 1-Dec-2020. Walenga J, Torres T, Jeske W, Schwartz J, Escalante V, Newman J and Bakhos M (2020) Protein C Pathway, Inflammation, and Pump Thrombosis in Patients With Left Ventricular Assist Devices, Clinical and Applied Thrombosis/Hemostasis, 10.1177/1076029620959724, 26, (107602962095972), Online publication date: 1-Jan-2020. Amiral J and Seghatchian J (2019) Revisiting the activated protein C-protein S-thrombomodulin ternary pathway: Impact of new understanding on its laboratory investigation, Transfusion and Apheresis Science, 10.1016/j.transci.2019.06.008, 58:4, (538-544), Online publication date: 1-Aug-2019. Prasad R and Sen P (2018) Phosphatidylcholine in the groove of endothelial cell protein C receptor (EPCR) regulates EPCR conformation and protein C recognition, Integrative Biology, 10.1039/C8IB00115D, 10:11, (696-704) Colling M and Bendapudi P (2018) Purpura Fulminans: Mechanism and Management of Dysregulated Hemostasis, Transfusion Medicine Reviews, 10.1016/j.tmrv.2017.10.001, 32:2, (69-76), Online publication date: 1-Apr-2018. Esper S (2017) Extracorporeal Membrane Oxygenation, Advances in Anesthesia, 10.1016/j.aan.2017.07.006, 35:1, (119-143), . Prasad R, Roy A and Sen P (2017) Functional Aspects of Activated Protein C (APC) in Regulating Homeostasis and Disease Proteases in Human Diseases, 10.1007/978-981-10-3162-5_18, (395-408), . Polderdijk S, Adams T, Ivanciu L, Camire R, Baglin T and Huntington J (2017) Design and characterization of an APC-specific serpin for the treatment of hemophilia, Blood, 10.1182/blood-2016-05-718635, 129:1, (105-113), Online publication date: 5-Jan-2017. Yang P, Wei X, Zhang J, Yi B, Zhang G, Yin L, Yang X and Sun J (2015) Antithrombotic Effects of Nur77 and Nor1 Are Mediated Through Upregulating Thrombomodulin Expression in Endothelial Cells, Arteriosclerosis, Thrombosis, and Vascular Biology, 36:2, (361-369), Online publication date: 1-Feb-2016. Louis-Jacques A, Maggio L and Romero S (2016) Prenatal Screening for Thrombophilias, Clinics in Laboratory Medicine, 10.1016/j.cll.2016.01.016, 36:2, (421-434), Online publication date: 1-Jun-2016. Melrose J (2016) Glycosaminoglycans in Wound Healing, Bone and Tissue Regeneration Insights, 10.4137/BTRI.S38670, 7, (BTRI.S38670), Online publication date: 1-Jan-2016. Kyhälä L, Lindström O, Kylänpää L, Mustonen H, Puolakkainen P, Kemppainen E, Tallgren M, Pettilä V, Repo H and Petäjä J (2015) Activated protein C retards recovery from coagulopathy in severe acute pancreatitis, Scandinavian Journal of Clinical and Laboratory Investigation, 10.3109/00365513.2015.1084041, 76:1, (10-16), Online publication date: 2-Jan-2016. Eliwan H, Watson R, Aslam S, Regan I, Philbin B, O'Hare F, O'Neill A, Preston R, Blanco A, Grant T, Nolan B, Smith O and Molloy E (2015) Neonatal brain injury and systemic inflammation: modulation by activated protein C ex vivo , Clinical and Experimental Immunology, 10.1111/cei.12453, 179:3, (477-484), Online publication date: 16-Feb-2015. Rizzo A, Fraidenburg D and Yuan J (2015) Pulmonary Vascular Physiology and Pathophysiology PanVascular Medicine, 10.1007/978-3-642-37078-6_202, (4057-4077), . Esper S, Levy J, Waters J and Welsby I (2014) Extracorporeal Membrane Oxygenation in the Adult, Anesthesia & Analgesia, 10.1213/ANE.0000000000000115, 118:4, (731-743), Online publication date: 1-Apr-2014. Crivellari M, Silvetti S, Gerli C, Landoni G, Franco A, Bove T, Pappalardo F and Zangrillo A (2014) Protein C zymogen in adults with severe sepsis or septic shock, Medicina Intensiva, 10.1016/j.medin.2013.04.005, 38:5, (278-282), Online publication date: 1-Jun-2014. Crivellari M, Silvetti S, Gerli C, Landoni G, Franco A, Bove T, Pappalardo F and Zangrillo A (2014) Protein C zymogen in adults with severe sepsis or septic shock, Medicina Intensiva (English Edition), 10.1016/j.medine.2013.04.004, 38:5, (278-282), Online publication date: 1-Jun-2014. Kelm D, Valerio-Rojas J, Cabello-Garza J, Gajic O and Cartin-Ceba R (2013) Predictors of Disseminated Intravascular Coagulation in Patients with Septic Shock, ISRN Critical Care, 10.5402/2013/219048, 2013, (1-6), Online publication date: 2-Oct-2013. Zhong X and Wright J (2013) Biological Insights into Therapeutic Protein Modifications throughout Trafficking and Their Biopharmaceutical Applications, International Journal of Cell Biology, 10.1155/2013/273086, 2013, (1-19), . Giannaki K, Politou M, Rouvas A, Merkouri E, Travlou A, Theodosiadis P and Gialeraki A (2013) Retinal vein occlusion, Blood Coagulation & Fibrinolysis, 10.1097/MBC.0b013e32835bfda1, 24:3, (279-283), Online publication date: 1-Apr-2013. Rizzo A, Fraidenburg D and Yuan J (2014) Pulmonary Vascular Physiology and Pathophysiology PanVascular Medicine, 10.1007/978-3-642-37393-0_202-1, (1-26), . Cubedo J, Ramaiola I, Padró T, Martin-Yuste V, Sabate-Tenas M and Badimon L (2017) High-molecular-weight kininogen and the intrinsic coagulation pathway in patients with de novo acute myocardial infarction, Thrombosis and Haemostasis, 10.1160/TH13-05-0381, 110:12, (1121-1134), . Erbas D (2013) Physiological Importance of Endothelium Endothelium, 10.1201/b14907-2, (1-71), Online publication date: 5-Jun-2013. Srikanthan K, Viswanathan N and Yuen J (2013) Free-Flap Failure in Thrombophilia, Annals of Plastic Surgery, 10.1097/SAP.0b013e3182586b47, 71:6, (675-681), Online publication date: 1-Dec-2013. Ebihara H, Zivcec M, Gardner D, Falzarano D, LaCasse R, Rosenke R, Long D, Haddock E, Fischer E, Kawaoka Y and Feldmann H (2012) A Syrian Golden Hamster Model Recapitulating Ebola Hemorrhagic Fever, The Journal of Infectious Diseases, 10.1093/infdis/jis626, 207:2, (306-318), Online publication date: 15-Jan-2013., Online publication date: 15-Jan-2013. Kurulgan Demirci E, Demirci T, Linder P, Trzewik J, Gierkowski J, Gossmann M, Kayser P, Porst D, Digel I, Artmann G and Temiz Artmann A (2012) rhAPC reduces the endothelial cell permeability via a decrease of contractile tensions induced by endothelial cells, Journal of Bioscience and Bioengineering, 10.1016/j.jbiosc.2012.03.019, 114:2, (212-219), Online publication date: 1-Aug-2012. Faienza M, Ventura A, Lauciello R, Crinò A, Ragusa L, Cavallo L, Spera S and Grugni G (2012) Analysis of Endothelial Protein C Receptor Gene and Metabolic Profile in Prader-Willi Syndrome and Obese Subjects, Obesity, 10.1038/oby.2011.349, 20:9, (1866-1870), Online publication date: 1-Sep-2012. Kyhälä L, Mentula P, Kylänpää L, Moilanen E, Puolakkainen P, Pettilä V and Repo H (2012) Activated Protein C Does Not Alleviate the Course of Systemic Inflammation in the APCAP Trial, International Journal of Inflammation, 10.1155/2012/712739, 2012, (1-8), . Puxty A, McConnell P, Crawley S, McAree S, Quasim T and Ramsay S (2011) Recombinant activated protein C usage in Scotland: a comparison with published guidelines and a survey of attitudes*, Anaesthesia, 10.1111/j.1365-2044.2011.06925.x, 67:1, (43-50), Online publication date: 1-Jan-2012. Ebihara H, Rockx B, Marzi A, Feldmann F, Haddock E, Brining D, LaCasse R, Gardner D and Feldmann H (2011) Host Response Dynamics Following Lethal Infection of Rhesus Macaques With Zaire ebolavirus, The Journal of Infectious Diseases, 10.1093/infdis/jir336, 204:suppl_3, (S991-S999), Online publication date: 1-Nov-2011., Online publication date: 1-Nov-2011. Gutovitz S, Papa L, Jimenez E, Falk J, Wieman L, Sawyer S and Giordano P (2011) Protein C as an early biomarker to distinguish pneumonia from sepsis, Journal of Critical Care, 10.1016/j.jcrc.2010.07.002, 26:3, (330.e9-330.e12), Online publication date: 1-Jun-2011. Azik F, Ertem M, Ileri T, Ince E, Uysal Z, Egin Y and Akar N (2009) Relation of Soluble Endothelial Protein C Receptor and Cytokines After Allogeneic Hematopoietic Stem Cell Transplantation, Clinical and Applied Thrombosis/Hemostasis, 10.1177/1076029609343449, 17:1, (94-99), Online publication date: 1-Feb-2011. ANDREOU A and CRAWLEY J (2011) Thrombomodulin analogues for the treatment of ischemic stroke, Journal of Thrombosis and Haemostasis, 10.1111/j.1538-7836.2011.04292.x, 9:6, (1171-1173), Online publication date: 1-Jun-2011. Kapur N, Bian C, Lin E, Deming C, Sperry J, Hansen B, Kakouros N and Rade J (2011) Inhibition of transforming growth factor-β restores endothelial thromboresistance in vein grafts, Journal of Vascular Surgery, 10.1016/j.jvs.2011.04.037, 54:4, (1117-1123.e1), Online publication date: 1-Oct-2011. Breitenstein A, Tanner F and Lüscher T (2010) Tissue Factor and Cardiovascular Disease: Quo Vadis?, Circulation Journal, 10.1253/circj.CJ-09-0818, 74:1, (3-12), . Lin Y, Shih S, Wu C, Chen Y, Chen Y and Lee S (2010) Experience of Using Activated Protein C in a Patient With Emphysematous Pyelonephritis Receiving Percutaneous Nephrostomy Drainage, International Journal of Gerontology, 10.1016/S1873-9598(10)70042-9, 4:3, (161-164), Online publication date: 1-Sep-2010. Huynh T, Nguyen N, Keller S, Moore C, Shin M and McKillop I (2010) Reducing Leukocyte Trafficking Preserves Hepatic Function After Sepsis, Journal of Trauma: Injury, Infection & Critical Care, 10.1097/TA.0b013e3181e65133, 69:2, (360-367), Online publication date: 1-Aug-2010. Carbone J and Rampersad R (2010) Prenatal Screening for Thrombophilias: Indications and Controversies, Clinics in Laboratory Medicine, 10.1016/j.cll.2010.05.003, 30:3, (747-760), Online publication date: 1-Sep-2010. Liu L and Gropper M (2010) Overview of Anesthesiology and Critical Care Medicine Miller's Anesthesia, 10.1016/B978-0-443-06959-8.00091-1, (2845-2867), . Hiroi T, Deming C, Zhao H, Hansen B, Arkenbout E, Myers T, McDevitt M and Rade J (2009) Proteasome Inhibitors Enhance Endothelial Thrombomodulin Expression via Induction of Krüppel-Like Transcription Factors, Arteriosclerosis, Thrombosis, and Vascular Biology, 29:10, (1587-1593), Online publication date: 1-Oct-2009. Yun N, Lee C and Lee S (2009) Protective effect of Aloe vera on polymicrobial sepsis in mice, Food and Chemical Toxicology, 10.1016/j.fct.2009.03.013, 47:6, (1341-1348), Online publication date: 1-Jun-2009. Stein E, McMahon B, Kwaan H, Altman J, Frankfurt O and Tallman M (2009) The coagulopathy of acute promyelocytic leukaemia revisited, Best Practice & Research Clinical Haematology, 10.1016/j.beha.2008.12.007, 22:1, (153-163), Online publication date: 1-Mar-2009. Esmon C (2009) Modulators of the Protein C Pathway New Therapeutic Agents in Thrombosis and Thrombolysis, 10.3109/9781420069242.020, (341-358), Online publication date: 1-Jun-2009. Mackman N (2009) The Role of Tissue Factor and Factor VIIa in Hemostasis, Anesthesia & Analgesia, 10.1213/ane.0b013e31819bceb1, 108:5, (1447-1452), Online publication date: 1-May-2009. Al-Rawi S, Woodward L and Knight J (2009) Puerperal streptococcal toxic shock syndrome treated with recombinant human activated protein C and intravenous immunoglobulin, International Journal of Obstetric Anesthesia, 10.1016/j.ijoa.2008.10.003, 18:2, (169-172), Online publication date: 1-Apr-2009. Byrnes M and Beilman G (2009) Adjunctive Measures for Treating Surgical Infections and Sepsis, Surgical Clinics of North America, 10.1016/j.suc.2008.09.001, 89:2, (349-363), Online publication date: 1-Apr-2009. Akima S, Hawthorne W, Favaloro E, Patel A, Blyth K, Mudaliar Y, Chapman J and O'Connell P (2009) Tirofiban and Activated Protein C Synergistically Inhibit the Instant Blood Mediated Inflammatory Reaction (IBMIR) from Allogeneic Islet Cells Exposure to Human Blood, American Journal of Transplantation, 10.1111/j.1600-6143.2009.02673.x, 9:7, (1533-1540), Online publication date: 1-Jul-2009. Altinisik J, Ates O, Ulutin T, Cengiz M and Buyru N (2007) Factor V Leiden, Prothrombin G20210A, and Protein C Mutation Frequency in Turkish Venous Thrombosis Patients, Clinical and Applied Thrombosis/Hemostasis, 10.1177/1076029607306404, 14:4, (415-420), Online publication date: 1-Oct-2008. Sharma S and Eschun G (2009) Hypotension and multiple organ dysfunction syndrome, Journal of Organ Dysfunction, 10.1080/17471060701200386, 4:3, (130-144), Online publication date: 1-Jan-2008. Chiba N, Nagao K, Mukoyama T, Tominaga Y and Tanjoh K (2008) Decreased activated protein C levels as a clinical predictor in patients with ST-elevation myocardial infarction, American Heart Journal, 10.1016/j.ahj.2008.06.015, 156:5, (931-938), Online publication date: 1-Nov-2008. Bredan A and Cauwels A (2016) Is There NO Treatment For Severe Sepsis?, Libyan Journal of Medicine, 10.3402/ljm.v3i1.4748, 3:1, (34-38), Online publication date: 1-Jan-2008. Schuster R and Waxman K (2007) Successful Treatment of Severe Sepsis With Recombinant Human Activated Protein C in a Patient With Traumatic Intracranial Hemorrhage, Journal of Trauma: Injury, Infection & Critical Care, 10.1097/01.ta.0000197599.76037.27, 63:2, (E34-E36), Online publication date: 1-Aug-2007. Kyung Kim H, Kim J, Chung J, Soon Lee D, Han K, Park S and Cho H (2007) Plasma level of stromal derived factor-1 (SDF-1) is increased in disseminated intravascular coagulation patients who have poor outcomes: In vitro effect of SDF-1 on coagulopathy, Thrombosis Research, 10.1016/j.thromres.2006.11.011, 120:4, (559-566), Online publication date: 1-Jan-2007. Hensley L, Stevens E, Yan S, Geisbert J, Macias W, Larsen T, Daddario‐DiCaprio K, Cassell G, Jahrling P and Geisbert T (2007) Recombinant Human Activated Protein C for the Postexposure Treatment of Ebola Hemorrhagic Fever, The Journal of Infectious Diseases, 10.1086/520598, 196:s2, (S390-S399), Online publication date: 15-Nov-2007. Grochowiecki T, Nazarewski S, Meszaros J, Kanski A, Wojtaszek M, Kosinski C, Wyzgal J and Szmidt J (2006) Use of Drotrecogin Alpha (Recombinant Human Activated Protein C, rhAPC) in the Treatment of Severe Sepsis Induced by Graft Pancreatitis After Simultaneous Pancreas and Kidney Transplantation: A Case Report, Transplantation Proceedings, 10.1016/j.transproceed.2005.11.071, 38:1, (276-279), Online publication date: 1-Jan-2006. de Groot P and Derksen R (2006) The Influence of Antiphospholipid Antibodies on the Protein C Pathway Hughes Syndrome, 10.1007/1-84628-009-5_34, (427-438), . Gempeler-Messina P and Müller C (2008) DIAGNOSTIC USE OF THE PROTEIN C ACTIVATOR FROM AGKISTRODON CONTORTRIX , Toxin Reviews, 10.1080/15569540600567362, 25:4, (335-349), Online publication date: 1-Jan-2006. Michaels R and Dorman T (2005) Evidence based medicine in the Intensive Care Unit: Improving care for the septic patient, Seminars in Anesthesia, Perioperative Medicine and Pain, 10.1053/j.sane.2004.11.009, 24:1, (41-49), Online publication date: 1-Mar-2005. Preston R, Villegas-Mendez A, Sun Y, Hermida J, Simioni P, Philippou H, Dahlbäck B and Lane D (2004) Selective modulation of protein C affinity for EPCR and phospholipids by Gla domain mutation, FEBS Journal, 10.1111/j.1432-1033.2004.04401.x, 272:1, (97-108) Hashmi S and Rogers S (2005) Current concepts in critical care, Journal of the American College of Surgeons, 10.1016/j.jamcollsurg.2004.08.019, 200:1, (88-95), Online publication date: 1-Jan-2005. Albisetti M, Andrew M and Monagle P (2005) Hemostatic abnormalities Neonatal Hematology, 10.1017/CBO9780511545306.015, (310-348) Bellomo R, Bonventre J, Macias W and Pinsky M (2005) Management of early acute renal failure: focus on post-injury prevention, Current Opinion in Critical Care, 10.1097/01.ccx.0000184165.02498.14, 11:6, (542-547), Online publication date: 1-Dec-2005. Buyru N, Altinisik J, Somay G and Ulutin T (2016) Factor V Leiden Mutation in Cerebrovascular Disease, Clinical and Applied Thrombosis/Hemostasis, 10.1177/107602960501100314, 11:3, (339-342), Online publication date: 1-Jul-2005. Sohn R, Deming C, Johns D, Champion H, Bian C, Gardner K and Rade J (2005) Regulation of endothelial thrombomodulin expression by inflammatory cytokines is mediated by activation of nuclear factor-kappa B, Blood, 10.1182/blood-2004-03-0928, 105:10, (3910-3917), Online publication date: 15-May-2005. Okajima K Regulation of inflammatory responses by activated protein C: the molecular mechanism(s) and therapeutic implications, Clinical Chemistry and Laboratory Medicine (CCLM), 10.1515/CCLM.2004.025, 42:2 Okada H, Takagi A, Murate T, Adachi T, Yamamoto K, Matsushita T, Takamatsu J, Sugita K, Sugimoto M, Yoshioka A, Yamazaki T, Saito H and Kojima T (2004) Identification of protein Sα gene mutations including four novel mutations in eight unrelated patients with protein S deficiency, British Journal of Haematology, 10.1111/j.1365-2141.2004.05026.x, 126:2, (219-225), Online publication date: 1-Jul-2004. Joyce D, Nelson D and Grinnell B (2004) Leukocyte and endothelial cell interactions in sepsis: Relevance of the protein C pathway, Critical Care Medicine, 10.1097/01.CCM.0000128037.72072.22, 32:Supplement, (S280-S286), Online publication date: 1-May-2004. Horstman L, Jy W, Jimenez J, Bidot C and Ahn Y (2004) New horizons in the analysis of circulating cell-derived microparticles, The Keio Journal of Medicine, 10.2302/kjm.53.210, 53:4, (210-230), . Brueckmann M, Hoffmann U, de Rossi L, Weiler H, Liebe V, Lang S, Kaden J, Borggrefe M, Haase K and Huhle G (2004) Activated protein C inhibits the release of macrophage inflammatory protein-1-alpha from THP-1 cells and from human monocytes, Cytokine, 10.1016/j.cyto.2004.01.004, 26:3, (106-113), Online publication date: 1-May-2004. Angus D, Laterre P, Helterbrand J, Ely E, Ball D, Garg R, Weissfeld L and Bernard G (2004) The effect of drotrecogin alfa (activated) on long-term survival after severe sepsis *, Critical Care Medicine, 10.1097/01.CCM.0000145228.62451.F6, 32:11, (2199-2206), Online publication date: 1-Nov-2004. Macias W, Yan S and Grinnell B (2018) The Development of Drotrecogin Alfa (Activated) for the Treatment of Severe Sepsis, The International Journal of Artificial Organs, 10.1177/039139880402700504, 27:5, (360-370), Online publication date: 1-May-2004. Laterre P, Levy H, Clermont G, Ball D, Garg R, Nelson D, Dhainaut J and Angus D (2004) Hospital mortality and resource use in subgroups of the Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) trial *, Critical Care Medicine, 10.1097/01.CCM.0000145231.71605.D8, 32:11, (2207-2218), Online publication date: 1-Nov-2004. Isobe H, Okajima K, Harada N, Liu W and Okabe H (2004) Activated protein C reduces stress-induced gastric mucosal injury in rats by inhibiting the endothelial cell injury, Journal of Thrombosis and Haemostasis, 10.1046/j.1538-7933.2003.00574.x, 2:2, (313-320), Online publication date: 1-Feb-2004. Galley H and Webster N (2004) Physiology of the endothelium, British Journal of Anaesthesia, 10.1093/bja/aeh163, 93:1, (105-113), Online publication date: 1-Jul-2004. Sperry J, Deming C, Bian C, Walinsky P, Kass D, Kolodgie F, Virmani R, Kim A and Rade J (2002) Wall Tension Is a Potent Negative Regulator of In Vivo Thrombomodulin Expression, Circulation Research, 92:1, (41-47), Online publication date: 10-Jan-2003. Angus D, Linde-Zwirble W, Clermont G, Ball D, Basson B, Ely E, Laterre P, Vincent J, Bernard G and van Hout B (2003) Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis*, Critical Care Medicine, 10.1097/00003246-200301000-00001, 31:1, (1-11), Online publication date: 1-Jan-2003. Tracy R (2003) Thrombin, Inflammation, and Cardiovascular Disease, Chest, 10.1378/chest.124.3_suppl.49S, 124:3, (49S-57S), Online publication date: 1-Sep-2003. Brueckmann M, Wizenmann J, Hoffmann U, Seeger M and Bewig B (2003) Clinical and laboratory effects of recombinant human activated protein C in the treatment of a patient with sepsis-induced multiple organ failure, Thrombosis Research, 10.1016/S0049-3848(03)00243-3, 109:5-6, (259-263), Online publication date: 1-Mar-2003. Levi M, Dörffler-Melly J, Reitsma P, Büller H, Florquin S, van der Poll T and Carmeliet P (2003) Aggravation of endotoxin-induced disseminated intravascular coagulation and cytokine activation in heterozygous protein-C–deficient mice, Blood, 10.1182/blood-2002-10-3254, 101:12, (4823-4827), Online publication date: 15-Jun-2003. UCHIBA M and OKAJIMA K (2003) , Japanese Journal of Thrombosis and Hemostasis, 10.2491/jjsth.14.519, 14:6, (519-522), . Vincent J, Angus D, Artigas A, Kalil A, Basson B, Jamal H, Johnson G and Bernard G (2003) Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial*, Critical Care Medicine, 10.1097/01.CCM.0000051515.56179.E1, 31:3, (834-840), Online publication date: 1-Mar-2003. Kleinpell R (2003) Advances in Treating Patients With Severe Sepsis, Critical Care Nurse, 10.4037/ccn2003.23.3.16, 23:3, (16-29), Online publication date: 1-Jun-2003. Wiel E and Vallet B (2003) A definite role for treatment with activated protein C in sepsis? Yes, Journal of Thrombosis and Haemostasis, 10.1111/j.1538-7836.2003.00542.x, 1:12, (2466-2468), Online publication date: 1-Dec-2003. Sharma S and Kumar A (2003) Septic shock, multiple organ failure, and acute respiratory distress syndrome, Current Opinion in Pulmonary Medicine, 10.1097/00063198-200305000-00008, 9:3, (199-209), Online publication date: 1-May-2003. Berg D, Gerlitz B, Shang J, Smith T, Santa P, Richardson M, Kurz K, Grinnell B, Mace K and Jones B (2003) Engineering the proteolytic specificity of activated protein C improves its pharmacological properties, Proceedings of the National Academy of Sciences, 10.1073/pnas.0736918100, 100:8, (4423-4428), Online publication date: 15-Apr-2003. Hopkins R (2002) Neurocognitive Impairment in Survivors of ARDS Yearbook of Intensive Care and Emergency Medicine 2002, 10.1007/978-3-642-56011-8_69, (765-773), . Hafer-Macko C, Ivey F, Gyure K, Sorkin J and Macko R (2002) Thrombomodulin Deficiency in Human Diabetic Nerve Microvasculature, Diabetes, 10.2337/diabetes.51.6.1957, 51:6, (1957-1963), Online publication date: 1-Jun-2002. Mizuno Y, Azuma H, Ito Y, Isotani E, Ohno K and Hirakawa K (2002) Inhibitory Effect of Activated Protein C on Cerebral Vasospasm After Subarachnoid Hemorrhage in the Rabbit, Journal of Cardiovascular Pharmacology, 10.1097/00005344-200205000-00014, 39:5, (729-738), Online publication date: 1-May-2002. Cvirn G, Gallistl S, Koestenberger M, Kutschera J, Leschnik B and Muntean W (2002) Alpha 2-macroglobulin enhances prothrombin activation and thrombin potential by inhibiting the anticoagulant protein C/protein S system in cord and adult plasma, Thrombosis Research, 10.1016/S0049-3848(02)00042-7, 105:5, (433-439), Online publication date: 1-Mar-2002. Macko R, Kittner S, Ivey F, Epstein A, Sparks M, Hebel J, Johnson C, Wityk R, Ueland P and Refsum H (2002) Effects of vitamin therapy on plasma total homocysteine, endothelial injury markers, and fibrinolysis in stroke patients, Journal of Stroke and Cerebrovascular Diseases, 10.1053/jscd.2002.123968, 11:1, (1-8), Online publication date: 1-Jan-2002. Sandusky G, Berg D, Richardson M, Myers L and Grinnell B (2002) Modulation of Thrombomodulin-dependent Activation of Human Protein C through Differential Expression of Endothelial Smads, Journal of Biological Chemistry, 10.1074/jbc.C200543200, 277:51, (49815-49819), Online publication date: 1-Dec-2002. Rudis M and Fish D (2002) Pharmacology, Clinical Efficacy, and Safety of Drotrecogin alfa (activated), Pharmacotherapy, 10.1592/phco.22.18.182S.33704, 22:12 Part 2, (182S-195S), Online publication date: 1-Dec-2002. Cvirn G, Gallistl S, Köstenberger M, Kutschera J, Leschnik B and Muntean W (2002) Alpha-2-Macroglobulin Level regulates the Anticoagulant Cofactor Activity of Protein S in Cord and Adult Plasma 31st Hemophilia Symposium Hamburg 2000, 10.1007/978-3-642-59383-3_39, (262-272), . Thude H, Wilkens A, Anders O and Barz D (2002) Analysis of the thrombomodulin gene in patients with venous thrombosis, Thrombosis Research, 10.1016/S0049-3848(02)00252-9, 107:3-4, (109-114), Online publication date: 1-Aug-2002. Bar-Or D, Rael L, Winkler J, Yukl R, Thomas G and Shimonkevitz R (2002) Copper Inhibits Activated Protein C: Protective Effect of Human Albumin and an Analogue of Its High-Affinity Copper-Binding Site, d-DAHK, Biochemical and Biophysical Research Communications, 10.1006/bbrc.2002.6363, 290:5, (1388-1392), Online publication date: 1-Feb-2002. Maki D (2002) Conclusions: drotrecogin alfa (activated)—from bench to practical use at the bedside, The American Journal of Surgery, 10.1016/S0002-9610(02)01136-4, 184:6, (S47-S50), Online publication date: 1-Dec-2002. Bernard G (2002) Foreword: severe sepsis, The American Journal of Surgery, 10.1016/S0002-9610(02)01131-5, 184:6, (S3-S4), Online publication date: 1-Dec-2002. Hopkins R (2002) Neurocognitive Impairment in Survivors of ARDS Intensive Care Medicine, 10.1007/978-1-4757-5551-0_69, (765-773), . Galligan L, Livingstone W, Volkov Y, Hokamp K, Murphy C, Lawler M, Fukudome K and Smith O (2001) Characterization of protein C receptor expression in monocytes, British Journal of Haematology, 10.1046/j.1365-2141.2001.03187.x, 115:2, (408-414), Online publication date: 1-Nov-2001. Roubey R (2001) Antiphospholipid Antibodies Vascular Manifestations of Systemic Autoimmune Diseases, 10.1201/9781420040395.ch3, Online publication date: 25-Jan-2001. Patricia Liaw C, Mather T, Oganesyan N, Ferrell G and Esmon C (2001) Identification of the Protein C/Activated Protein C Binding Sites on the Endothelial Cell Protein C Receptor, Journal of Biological Chemistry, 10.1074/jbc.M010572200, 276:11, (8364-8370), Online publication date: 1-Mar-2001. Pickering W, Marriott K and Regan L (2016) G20210A Prothrombin Gene Mutation: Prevalence in a Recurrent Miscarriage Population, Clinical and Applied Thrombosis/Hemostasis, 10.1177/107602960100700106, 7:1, (25-28), Online publication date: 1-Jan-2001. Joyce D, Gelbert L, Ciaccia A, DeHoff B and Grinnell B (2001) Gene Expression Profile of Antithrombotic Protein C Defines New Mechanisms Modulating Inflammation and Apoptosis, Journal of Biological Chemistry, 10.1074/jbc.C100017200, 276:14, (11199-11203), Online publication date: 1-Apr-2001. Bernard G, Vincent J, Laterre P, LaRosa S, Dhainaut J, Lopez-Rodriguez A, Steingrub J, Garber G, Helterbrand J, Ely E and Fisher C (2001) Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis, New England Journal of Medicine, 10.1056/NEJM200103083441001, 344:10, (699-709), Online publication date: 8-Mar-2001. Yin Z, Huang Z, Cui J, Fiehler R, Lasky N, Ginsburg D and Broze G (2000) Prothrombotic phenotype of protein Z deficiency, Proceedings of the National Academy of Sciences, 10.1073/pnas.120081897, 97:12, (6734-6738), Online publication date: 6-Jun-2000. TAOKA Y and OKAJIMA K (2000) Role of Leukocytes in Spinal Cord Injury in Rats, Journal of Neurotrauma, 10.1089/neu.2000.17.219, 17:3, (219-229), Online publication date: 1-Mar-2000. Liaw P, Neuenschwander P, Smirnov M and Esmon C (2000) Mechanisms by Which Soluble Endothelial Cell Protein C Receptor Modulates Protein C and Activated Protein C Function, Journal of Biological Chemistry, 10.1074/jbc.275.8.5447, 275:8, (5447-5452), Online publication date: 1-Feb-2000. Moscatelli D, Bikfalvi A, Bini A, Haidaris P, Kudryk B, Carmeliet P and Collen D (2000) F Encyclopedic Reference of Vascular Biology & Pathology, 10.1007/978-3-642-57063-6_6, (90-143), . Hirose K, Okajima K, Taoka Y, Uchiba M, Tagami H, Nakano K, Utoh J, Okabe H and Kitamura N (2000) Activated Protein C Reduces the Ischemia/Reperfusion-Induced Spinal Cord Injury in Rats by Inhibiting Neutrophil Activation, Annals of Surgery, 10.1097/00000658-200008000-00018, 232:2, (272-280), Online publication date: 1-Aug-2000. Mizutani A, Okajima K, Uchiba M and Noguchi T (2000) Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation, Blood, 10.1182/blood.V95.12.3781.012k18_3781_3787, 95:12, (3781-3787), Online publication date: 15-Jun-2000. de Groot P and Derksen R (2000) The Influence of Antiphospholipid Antibodies on the Protein C Pathway Hughes Syndrome, 10.1007/978-1-4471-3666-8_31, (307-316), . Leblond L, Grouix B, Boudreau C, Yang Q, Siddiqui M and Winoco
Referência(s)